Battle buddies: rapid deployment of a psychological resilience intervention for health care workers during the COVID-19 pandemic CS Albott, JR Wozniak, BP McGlinch, MH Wall, BS Gold, S Vinogradov Anesthesia & Analgesia 131 (1), 43-54, 2020 | 545 | 2020 |
Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression PR Shiroma, B Johns, M Kuskowski, J Wels, P Thuras, CS Albott, KO Lim Journal of affective disorders 155, 123-129, 2014 | 225 | 2014 |
Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression PR Shiroma, CS Albott, B Johns, P Thuras, J Wels, KO Lim International Journal of Neuropsychopharmacology 17 (11), 1805-1813, 2014 | 131 | 2014 |
Efficacy, safety, and durability of repeated ketamine infusions for comorbid posttraumatic stress disorder and treatment-resistant depression CS Albott, KO Lim, MK Forbes, C Erbes, SJ Tye, JG Grabowski, P Thuras, ... The Journal of clinical psychiatry 79 (3), 17462, 2018 | 125 | 2018 |
Association of childhood adversity with differential susceptibility of transdiagnostic psychopathology to environmental stress in adulthood CS Albott, MK Forbes, JJ Anker JAMA network open 1 (7), e185354-e185354, 2018 | 87 | 2018 |
Intravenous ketamine for adolescents with treatment-resistant depression: an open-label study KR Cullen, P Amatya, MG Roback, CS Albott, M Westlund Schreiner, ... Journal of child and adolescent psychopharmacology 28 (7), 437-444, 2018 | 78 | 2018 |
A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression PR Shiroma, P Thuras, J Wels, CS Albott, C Erbes, S Tye, KO Lim Translational psychiatry 10 (1), 206, 2020 | 75 | 2020 |
The antidepressant effect of repeat dose intravenous ketamine is delayed by concurrent benzodiazepine use CS Albott, PR Shiroma, KR Cullen, B Johns, P Thuras, J Wels, KO Lim The Journal of clinical psychiatry 78 (3), 1863, 2017 | 39 | 2017 |
Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression PR Shiroma, P Thuras, J Wels, CS Albott, C Erbes, S Tye, KO Lim Journal of Affective Disorders 277, 470-477, 2020 | 34 | 2020 |
Brain entropy and neurotrophic molecular markers accompanying clinical improvement after ketamine: preliminary evidence in adolescents with treatment-resistant depression AV Roy, M Thai, B Klimes-Dougan, M Westlund Schreiner, BA Mueller, ... Journal of Psychopharmacology 35 (2), 168-177, 2021 | 21 | 2021 |
Batres-Y-Carr, TM, Wels, J., & Shiroma, PR (2018). Efficacy, safety, and durability of repeated ketamine infusions for comorbid posttraumatic stress disorder and treatment … CS Albott, KO Lim, MK Forbes, C Erbes, SJ Tye, JG Grabowski, P Thuras J. Clin. Psychiatry 79, 0 | 13 | |
Neural and behavioral correlates of clinical improvement to ketamine in adolescents with treatment resistant depression M Thai, Z Başgöze, B Klimes-Dougan, BA Mueller, M Fiecas, KO Lim, ... Frontiers in Psychiatry 11, 820, 2020 | 10 | 2020 |
The effect of repeated ketamine infusion over facial emotion recognition in treatment-resistant depression: a preliminary report PR Shiroma, CS Albott, B Johns, P Thuras, J Wels, KO Lim The Journal of Neuropsychiatry and Clinical Neurosciences 27 (4), 362-364, 2015 | 9 | 2015 |
Advances and challenges in transcranial magnetic stimulation (TMS) research on motor systems M Chen, CC Cline, KL Frost, TJ Kimberley, ST Nemanich, BT Gillick, ... Engineering in Medicine, 283-318, 2019 | 7 | 2019 |
Neurocognitive effects of repeated ketamine infusions in comorbid posttraumatic stress disorder and major depressive disorder CS Albott, KO Lim, C Erbes, P Thuras, J Wels, SJ Tye, PR Shiroma Journal of Affective Disorders 308, 289-297, 2022 | 5 | 2022 |
Characterization of comorbid posttraumatic stress disorder and major depressive disorder using ketamine as an experimental medicine probe CS Albott, S Lee, KR Cullen, P Thuras, S Lissek, J Wels, KJ Friedrich, ... Journal of psychiatry and brain science 6, 2021 | 3 | 2021 |
Parkinson Disease: Current and Emerging Treatment Strategies. A Ramirez-Zamora The Journal of Clinical Psychiatry 79 (3), PP17030TX1C-PP17030TX1C, 2018 | 3 | 2018 |
3525 improvement in suicidal ideation after repeated ketamine infusions: Relationship to reductions in symptoms of posttraumatic stress disorder, depression, and pain CS Albott, KO Lim, MK Forbes, P Thuras, J Wels, S Tye, P Shiroma Journal of Clinical and Translational Science 3 (s1), 46-46, 2019 | 2 | 2019 |
267. outcomes from University of Minnesota clinical RTMS clinic for treatment-resistant depression: RTMS effects on suicidal Ideation as a function of baseline Anhedonia AI Sonmez, AM Kruger, C Godoy-Henderson, C Sullivan, S Schmid, ... Biological Psychiatry 93 (9), S201, 2023 | 1 | 2023 |
Concurrent Benzodiazepine Use and TMS Clinical Outcomes S Wilson, S Olsen, C Sullivan, D Cooper, I Somez, AS Widge, CS Albott, ... Biological Psychiatry 89 (9), S288, 2021 | 1 | 2021 |